Gemtu (Gemcitabine HCL) 1000mg/10ml, 2000mg/20ml, 200mg/2ml
Product Description
Onko Ilac Sanayi ve Ticaret A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Onko Ilac Sanayi ve Ticaret A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Onko Ilac Sanayi ve Ticaret A.S. (35)
-
Product Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion
Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion is used to treat bladder cancer, breast cancer, head and neck cancer, stomach and pancreatic cancer, prostate cancer and cervical cancer. Contact us for more information. -
Product Docetu (Docetaxel) 20 mg/ml, 80 mg/ml, 160 mg/8 ml
Docetaxel is an antineoplastic agent. It is prepared by semisynthesis beginning with a precursor extracted from the renewable needle biomass of yew plants. Docetaxel is a white to almost-white powder with an empirical formula of C43H53NO14• 3H2O, and a molecular weight of 861.9. It... -
Product Epiritu (Epirubicine HCL) 10 mg/5 ml, 200 mg/100 ml, 50 mg/25 ml
Epiritu is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "anthracyline antitumor antibiotic. Epiritu is used to treat breast cancer. It is used as adjuvant therapy in women who have had surgery and have lymph node involvement.May be... -
Product Azacitidine Injection 100mg/vial (Azacitidine)
This medication is used to treat a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS) in which the bone marrow does not produce enough healthy blood cells -
Product Bortezomib Injection 3.5 mg vial (Bortezomib)
It is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma -
Product Doxtu (Doxorubicine HCL) 10 mg/5 ml, 50 mg/25 ml
Doxtu is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Doxorubicin is classified as an “anthracycline antibiotic.” Doxtu is administered via an intravenous (IV) injection through a central line or a peripheral venous line, and the drug is given over several minutes. Contact us fo... -
Product Paclitu (Paclitaxel) 100mg/16.7 ml, 300 mg/50 ml, 150 mg/25 ml, 30 mg/5 ml
Paclitu injection is used to treat advanced cancer of the ovaries, breast, non-small cell lung cancer, and Kaposi sarcoma. Kaposi sarcoma is a cancer of the skin and mucous membranes that is commonly found in patients with acquired immunodeficiency syndrome (AIDS). Paclitu belongs to the group of medi... -
Product Topotu 4mg/4ml (Topotecan HCL)
Topotu (topotecan hydrochloride) is a semi-synthetic derivative of camptothecin and is an anti-tumor drug with topoisomerase I-inhibitory activity. Topotu for Injection is supplied as a sterile, lyophilized, buffered, light yellow to greenish powder available in single-dose vials. Topotu for inje... -
Product Zomtu 4mg/100ml, 4mg/5ml (Zoledronic Acid)
Zomtu contains zoledronic acid. It belongs to a group of medicines called bisphosphonates. Zoledronic acid inhibits the release of calcium from bones.
Zomtu is used to treats Paget's disease and osteoporosis in postmenopausal women. Contact us for more information
-
Product 5-Frotu (5-Fluorouracil) 1000 mg/20 ml - 5000 mg/ 100ml
5-fluorouracil is a nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the convers... -
Product PAKSITU (Paricalcitol) 10 MCG/2ML - 2MCG/ML - 5MCG/ML
Paricalcitol is a synthetic noncalcemic, nonphosphatemic vitamin D analogue. Paricalcitol binds to the vitamin D receptor and has been shown to reduce parathyroid hormone (PTH) levels. -
Product Busulphan 60mg/10ml (Busulphan)
Busulfan is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate
Onko Ilac Sanayi ve Ticaret A.S. resources (2)
-
News Bortezomib Injection 3.5 mg vial DCP application
Onko Koçsel is proud that Bortezomib Injection 3.5 mg vial DCP application has been successfully accepted by EMA member countries on March, 2021. Onko Koçsel is open for collaboration within and outside EU countries.
-
Video Onko Kocsel Factory video
Onko Kocsel Factory video
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance